321 developer-"https:" "https:" "https:" "UCL" "UCL" "UCL" Postdoctoral research jobs at Nature Careers
Sort by
Refine Your Search
-
Listed
-
Country
-
Field
-
The Microsystems and Nanotechnology Division at the National Institute of Standards and Technology (NIST), Gaithersburg, MD, is seeking postdoctoral researchers highly motivated to develop next
-
the development and application of advanced optical imaging and microscopy methods. The Hillman Lab brings together researchers from physics, engineering, and biology in a collaborative and intellectually open
-
team to primarily meet the postdoctoral recruitment needs of St. Jude Children's Research Hospital by developing and implementing effective recruiting strategies. This position requires travel
-
human health. Within this mission, the Jug Group develops advanced computational methods and open scientific software to extract knowledge from complex biological imaging data. We work at the intersection
-
Nordisk NERD grant, which will fund our research activities in quantum materials for the next 7 years. What we offer The successful candidate is offered: access to a well-developed research infrastructure
-
-generation AI models of gene regulation and disease progression. Our work is redefining Parkinson’s disease biology and enabling translational breakthroughs. The role Develop deep learning models across genome
-
in nanotechnology may also be considered. The Zhang laboratory functions as an integrated translational research program with the goal of designing and developing new immunotherapies and immunologic
-
Research Center (CORC). The successful candidate will contribute to the HyperCap research program by developing improved and cost-efficient synthesis routes for thermodynamic promoter systems used in gas
-
Intelligence (AI) approaches and methods with the long-term objective of improving clinical cancer care. The training, project development, and application will be mentored by Dr. Peter Nelson and Dr. Jeff Leek
-
inhouse developed long-acting GLP-1 receptor agonist, Efsubaglutide alfa , has achieved regulatory approval and market access in China representing a major milestone in biologics innovation originating from